(2-[18F]fluoropropionyl-(d)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice

This publication has 13 references indexed in Scilit:

• Recommendations for fluorine-18 production
  Published by Elsevier ,2002
• In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats
  Life Sciences, 1991
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991
• Fluorine-18 labeling of monoclonal antibodies and fragments with preservation of immunoreactivity
  Bioconjugate Chemistry, 1991
• Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors
  New England Journal of Medicine, 1990
• Parallelin Vivoandin VitroDetection of Functional Somatostatin Receptors in Human Endocrine Pancreatic Tumors: Consequences with Regard to Diagnosis, Localization, and Therapy
  Journal of Clinical Endocrinology & Metabolism, 1990
• Identification and characterization of somatostatin receptors in neonatal rat long bones
  Biochemical Journal, 1990
• LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
  The Lancet, 1989
• N.C.A. ¹⁸F‐fluoroacylation via fluorocarboxylic acid esters
  Journal of Labelled Compounds and Radiopharmaceuticals, 1988
• New specific radioligand for one subpopulation of brain somatostatin receptors
  Life Sciences, 1985